Global Regenerative Medicine Market

A New Era in Human Health to Resolve Unmet Medical Needs

Regular Price: USD 3,950

Special Price USD 3,555

10% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 3,555

PAY BY INVOICE

Be the first to review this product

This research service focuses on the 4 broad segments of the regenerative medicine market, namely cell therapy, gene therapy, tissue engineering, and small molecules and biologics. A detailed overview of the cell therapy segment, including the major commercialised products and products in development, has been provided. Additionally, key clinical milestones, timelines of key clinical events, key companies to watch, and a strategic partnership assessment in the global regenerative market have been included. An overview of the other segments—gene therapy, tissue engineering, and small molecules and biologics—has also been provided.

Table of Contents

Executive SummaryExecutive SummaryExecutive Summary (continued)Regenerative Medicine Market—Game-changing StrategiesMethodology and ScopeIntroductionIntroductionIntroduction (continued)Introduction (continued)Market Overview—SegmentationMarket Overview—Cell Therapy (CT)Segment Market Overview—Cell Therapy (CT)Segment (continued) Market Overview—Cell Therapy (CT)Segment (continued) Market Overview—Cell Therapy (CT)Segment (continued) Market Overview—Gene Therapy (GT) SegmentMarket Overview—Tissue Engineering (TE) SegmentMarket Overview—Small Molecules and Biologics SegmentCell Therapy Regenerative Medicine SegmentCell Therapy—Competitive Landscape of Marketed ProductsCell Therapy—Competitive Landscape of Products in DevelopmentCell Therapy—Market SegmentationCell Therapy—Marketed Products SynopsisCell Therapy—Marketed Products Synopsis (continued)Cell Therapy—Marketed Products Synopsis (continued)Cell Therapy—Marketed Products Synopsis (continued)Product Dashboard of Leading Commercial Cell Therapy Regenerative ProductsProduct Dashboard—Apligraf (Organogenesis)Product Dashboard—GINTUIT (Organogenesis)Product Dashboard—Provenge (Dendreon)Product Dashboard—Grafix (Osiris Therapeutics)Product Dashboard—Dermagraft (Shire)Product Dashboard—Osteocel Plus (NuVasive)Product Dashboard—ReCell Spray-On Skin (Avita Medical)Product Dashboard—Trinity Evolution (Orthofix)Product Dashboard—BioDfactor (BioD, LLC)Product Dashboard—BioDfence (BioD, LLC)Cell Therapy—Pipeline SynopsisCell Therapy—Pipeline Synopsis (continued)Cell Therapy—Pipeline Synopsis (continued)Cell Therapy—Pipeline Synopsis (continued)Cell Therapy—Pipeline Synopsis (continued)Cell Therapy—Pipeline Synopsis (continued)Cell Therapy—Pipeline Synopsis (continued)Cell Therapy—Pipeline Synopsis (continued)Cell Therapy Regenerative Medicine Segment—Major Clinical MilestonesCell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued) Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued) Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued) Cell Therapy Regenerative Medicine Segment—Major On-going/Recently Completed Clinical Trials (continued) Cell Therapy Regenerative Medicine Segment—Pipeline Assets by CompanyCell Therapy—Pipeline BreakdownCompany—Aastrom Biosciences, Inc.Company—Advanced Cell Technology, Inc.Company—Aldagen, Inc. (Acquired by Cytomedix)Company—Athersys, Inc.Company—Celgene Cellular Therapeutics Company—Cellerant Therapeutics, Inc.Company—Gamida Cell Ltd. Company—Garnet BioTherapeuticsCompany—Histogenics Company—Mesoblast Ltd.Company—Neuralstem, Inc.Company—Osiris Therapeutics, Inc.Company—Pluristem Therapeutics, Inc.Company—SanBio, Inc.Company—StemCells, Inc.Company—TCA Cellular Therapy, LLCCompany—TiGenix NV Gene Therapy Regenerative Medicine SegmentGene Therapy OverviewGene Therapy Overview (continued)Gene Therapy Overview (continued)Key Company to Watch—Juventas Therapeutics Inc. Tissue Engineering Regenerative Medicine Segment Tissue Engineering OverviewTissue Engineering Overview (continued)Tissue Engineering Overview (continued)Tissue Engineering Overview (continued)Tissue Engineering Overview (continued)Small Molecules and Biologics Regenerative Medicine Segment Small Molecules and Biologics OverviewSmall Molecules and Biologics Overview (continued)Regenerative Medicine Market—Key Companies to Watch by Therapeutic SegmentsCardiovascular Disease (CVD) Regenerative Medicine Market Cardiovascular Disease (CVD) Regenerative Medicine Market (continued) Cardiovascular Disease (CVD) Regenerative Medicine Market (continued) Vascular Disease Regenerative Medicine Market Vascular Disease Regenerative Medicine Market (continued) Non-Healing Wounds Regenerative Medicine Market Non-Healing Wounds Regenerative Medicine Market (continued) Spinal Cord Injury Regenerative Medicine Market Spinal Cord Injury Regenerative Medicine Market (continued)Spinal Cord Injury Regenerative Medicine Market (continued)Alzheimer’s Disease Regenerative Medicine Market Alzheimer’s Disease Regenerative Medicine Market (continued)Parkinson’s Disease (PD) Regenerative Medicine Market Musculoskeletal Regenerative Medicine Market Musculoskeletal Regenerative Medicine Market (continued) Musculoskeletal Regenerative Medicine Market (continued) Autoimmune Disorders Regenerative Medicine Market Autoimmune Disorders Regenerative Medicine Market (continued) Autoimmune Disorders Regenerative Medicine Market (continued) Stroke Regenerative Medicine Market Stroke Regenerative Medicine Market (continued) Diabetes Regenerative Medicine Market Diabetes Regenerative Medicine Market (continued) Ocular Diseases Regenerative Medicine Market Ocular Diseases Regenerative Medicine Market (continued) Regenerative Medicine Market—Timeline of Key EventsRegenerative Medicine Market—Timeline of Key EventsRegenerative Medicine Market—Timeline of Key Events (continued)Regenerative Medicine Market—Timeline of Key Events (continued)Regenerative Medicine Market—Timeline of Key Events (continued)Regenerative Medicine Market—Merger, Acquisition, and Partnership AssessmentRegenerative Medicine Market—Merger, Acquisition, and Partnership AssessmentRegenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)Regenerative Medicine Market—Merger, Acquisition, and Partnership Assessment (continued)Regenerative Medicine Market—Funding Scenario Regenerative Medicine Market—Funding ScenarioRegenerative Medicine Market—Funding Scenario (continued)Regenerative Medicine Market—Funding Scenario (continued)Regenerative Medicine Market—Funding Scenario (continued)ConclusionsConclusions and RecommendationsLegal DisclaimerAppendixHuman Embryonic Stem Cells OverviewMesenchymal Stem Cells OverviewNeural Stem Cells OverviewInduced Pluripotent Stem Cells OverviewStem Cell Types in DevelopmentList of AbbreviationsThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue PropositionGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Related Research

Release Date : 18-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Release Date : 18-Sep-17

Region : North America

Release Date : 15-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.